Glaxo Profits Reflect Strong Sterling
Stock quotes in this article:
GSK
Generic-drug competition played a key role in flat earnings and slipping sales during the first quarter for GlaxoSmithKline(GSK Quote).
The British drug giant said Wednesday that first-quarter operating profit was flat vs. the year-ago quarter; net earnings per share rose 2%; and revenue declined 4% when measured in British pounds sterling. However, when measured in constant exchange rates, GlaxoSmithKline said operating profit rose 11%, net earnings per share gained 14% and revenue gained 4%. The weak U.S. dollar had a significant impact. One British pound was worth $1.96 during the quarter, up from $1.75 in the year-ago quarter; the pound also advanced vs. the Japanese yen and the euro. Translated into U.S. dollars, GlaxoSmithKline reported a first-quarter operating profit of $4.25 billion, net earnings per share of 53 cents and revenue of $10.96 billion. The constant-exchange rate data are "very encouraging" and show that the company "will continue to deliver strong earnings performance," said CEO Jean-Pierre Garnier. He reiterated a full-year earnings-per-share forecast of 8% to 10% growth in constant exchange rates. Among major products, sales of the Advair asthma medication rose 11% to $1.64 billion vs. the year-ago quarter when measured in constant exchange rates. The herpes drug Valtrex gained 22% to $439 million, while the combined sales of several HIV/AIDS drugs slipped 3% to $704 million.- Loading Comments...
- Loading Comments...
Featured Photo Galleries
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,270.47 | 1,093.48 | 2,167.88 | 34.29 |
Oil *
75.55
|
|
UP
73.00
|
UP
6.24
|
UP
18.86
|
DOWN
0.17
|
10 Yr
3.43%
SPDR Gold
109.74
|
|
+0.72%
|
+0.57%
|
+0.88%
|
-0.49%
|
Data delayed 20 minutes |














